Of note, a case report demonstrated that the pathogenic nature of IgG4 autoantibodies directed against CFH could trigger the C’-mediated thrombotic microangiopathy in a patient carrying a genetic predisposition for homozygote CFHR1/4 gene deletion [49]. This evidence concerns the gene CFH and Genetic thrombotic microangiopathy.